James G A, Thostenson J D, Brown G, Carter G, Hayes H, Tripathi S P, Dobry D J, Govindan R B, Dornhoffer J L, Williams D K, Kilts C D, Mennemeier M S
University of Arkansas for Medical Sciences, 4301 W. Markham St #554, Little Rock, AR 72205-7199, United States.
University of Arkansas for Medical Sciences, 4301 W. Markham St #554, Little Rock, AR 72205-7199, United States.
Brain Stimul. 2017 Sep-Oct;10(5):934-943. doi: 10.1016/j.brs.2017.05.009. Epub 2017 Jun 2.
Subjective idiopathic tinnitus is an intrusive, distracting, and potentially disabling disorder characterized by phantom perception of sounds. Although tinnitus has no approved pharmacologic treatment, recent evidence supports the use of repetitive transcranial magnetic stimulation (rTMS) to alleviate tinnitus symptoms.
OBJECTIVE/HYPOTHESIS: Repetitive TMS delivered over the middle superior temporal gyrus (STG) may alter ratings of tinnitus awareness and annoyance more than loudness due to change in attentional processing. STG has reciprocal connections to regions of the prefrontal cortex that mediate attention. To probe the hypothesized influence of STG stimulation on attention, a subset of patients with tinnitus enrolled in an rTMS clinical trial [n = 12, 9 male, mean (sd) age = 49 (15) years] underwent an attentional conflict task before and after rTMS treatment in a repeated-measures functional magnetic resonance imaging (fMRI) study.
The Multi-Source Interference Task (MSIT), a Stroop-based visual attentional conflict fMRI task, was used to map participants' neural processing of attentional conflict prior to rTMS intervention (Baseline) and after three rTMS intervention arms: Sham, 1 Hz, and 10 Hz (four sessions per arm, 1800 pulses per session, delivered @110% of the motor threshold over the posterior superior temporal gyrus).
All measures of tinnitus severity (awareness, loudness, and annoyance) improved with 1 Hz rTMS intervention; however, the greatest and most robust changes were observed for ratings of tinnitus awareness (mean 16% reduction in severity from Baseline, p < 0.01). The MSIT elicited a similar pattern of neural activation among tinnitus participants at Baseline compared to an independent sample of 43 healthy comparison adults (r = 0.801, p = 0.001). Linear regression with bootstrap resampling showed that greater recruitment of bilateral prefrontal and bilateral parietal regions by MSIT at Baseline corresponded with poorer treatment response. Individual regions' activities explained 37-67% variance in participant treatment response, with left dorsolateral prefrontal cortex's MSIT activity at Baseline explaining the greatest reduction in tinnitus awareness following 1 Hz stimulation. Although left dorsolateral prefrontal cortex activity at Baseline also predicted reduction in tinnitus loudness and annoyance (∼50% variance explained), these symptoms were more strongly predicted by right middle occipital cortex (∼70% variance explained) - suggesting that the neural predictors of symptom-specific treatment outcomes may be dissociable.
These candidate neural reactivity markers of treatment response have potential clinical value in identifying tinnitus sufferers who would or would not therapeutically benefit from rTMS intervention.
主观性特发性耳鸣是一种侵扰性、分散注意力且可能致残的疾病,其特征为对声音的幻听。尽管耳鸣尚无获批的药物治疗方法,但近期证据支持使用重复经颅磁刺激(rTMS)来缓解耳鸣症状。
目的/假设:由于注意力加工的改变,在颞上回中部(STG)进行重复经颅磁刺激可能比改变响度更能改变耳鸣知晓度和烦恼度的评分。STG与介导注意力的前额叶皮质区域存在相互连接。为探究STG刺激对注意力的假定影响,一项rTMS临床试验中的部分耳鸣患者(n = 12,9名男性,平均(标准差)年龄 = 49(15)岁)在重复测量功能磁共振成像(fMRI)研究中于rTMS治疗前后接受了注意力冲突任务。
多源干扰任务(MSIT)是一种基于斯特鲁普效应的视觉注意力冲突fMRI任务,用于在rTMS干预前(基线)以及三个rTMS干预组(假刺激、1Hz和10Hz)后描绘参与者对注意力冲突的神经加工情况(每组四个疗程,每个疗程1800个脉冲,在颞上回后部以运动阈值的110%施加)。
1Hz rTMS干预后,耳鸣严重程度的所有指标(知晓度、响度和烦恼度)均有所改善;然而,耳鸣知晓度评分出现了最大且最显著的变化(与基线相比严重程度平均降低16%,p < 0.01)。与43名健康对照成年人的独立样本相比,MSIT在基线时在耳鸣参与者中引发了相似的神经激活模式(r = 0.801,p = 0.001)。采用自助重采样的线性回归表明,基线时MSIT对双侧前额叶和双侧顶叶区域的更大募集与较差的治疗反应相关。各个区域的活动解释了参与者治疗反应中37 - 67%的方差,基线时左侧背外侧前额叶皮质的MSIT活动解释了1Hz刺激后耳鸣知晓度的最大降低。尽管基线时左侧背外侧前额叶皮质活动也预测了耳鸣响度和烦恼度的降低(解释了约50%的方差),但这些症状由右侧枕中皮质的预测更强(解释了约70%的方差)——这表明症状特异性治疗结果的神经预测指标可能是可分离的。
这些治疗反应的候选神经反应性标志物在识别可能从rTMS干预中获益或无法获益的耳鸣患者方面具有潜在临床价值。